Recruiting NA Supplemental Oxygen

New treatment option for Supplemental Oxygen

Official title Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients

ClinicalTrials.gov ID: NCT06780813

What this study is testing

What it's testing
The incidence of surgical-site infection (SSI) and complications related to wound healing reaches 10-20% of gynecological cancer patients. Each complication may dramatically prolong the hospitalization period and increase the economic burden of hospital care.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 85, women only

You may be able to join if

  • Obese (BMI\>30kg/m2) gynecological cancer patients
  • Optimized preoperative CBC values (hemoglobin \>11g/dl, WBC 4.000-11.000 X 109/L, platelets 150,000 to 400,000 X 109/L)
  • In the case of neoadjuvant therapy an interval longer than three weeks between the last cycle and the operation

You likely can't join if

  • Active immunosuppresion
  • Preexisting infection of the abdominal wall
  • Preexisting sepsis

The study team makes the final eligibility decision.

Where it's taking place

  • Athens, Greece

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 85 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Athens, Greece. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.